AI assistant
LABCORP HOLDINGS INC. — Director's Dealing 2020
Feb 8, 2020
30237_dirs_2020-02-07_7e0c5bcb-286d-4fc7-b5b3-8eb5f71b1cb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-04
Reporting Person: van der Vaart Sandra D (SVP, Global General Counsel)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-04 | Restricted Stock Unit | $ | A | 900 | Acquired | Common Stock (900) | Direct | |
| 2020-02-04 | Non-qualified Stock Options | $182.51 | A | 3900 | Acquired | 2030-02-03 | Common Stock (3900) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: This amended form is filed to update the number of Employee Stock Options and Restricted Stock Units awarded and set for on Table II.
F3: The Restricted Stock Units vest in three equal annual installments beginning on February 4, 2021.
F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F5: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F6: The option vests in three equal annual installments beginning on the date reflected in this column.